♟️ Thursday 30 April 2026 Thu, 30 Apr 2026

Yugo Metals (ASX:YUG) secured government approval for its Petrovo tenement in Bosnia, while initial drilling at Sinjakovo’s Kovacevac and Erak prospects delivered promising polymetallic results. The company also appointed Petar Tomašević as permanent CEO, positioning itself for further exploration progress.

Titan Minerals boosts its Dynasty Gold Project resource to 3.9 million ounces of gold and 26.1 million ounces of silver, driven by extensive drilling at Cerro Verde and discovery of porphyry mineralisation at Kaliman. A major 30,000m drilling campaign is planned for 2026 alongside advancing feasibility studies.

Maronan Metals secured Mineral Development Licence 2028, unlocking underground exploration, while metallurgical tests showed gold recoveries up to 88% and copper recoveries exceeding 96%. The company expanded its drilling program and bolstered leadership amid steady progress toward mine development.

Racura Oncology reported robust progress in Q3 FY2026, including launching a key lung cancer trial and unveiling a novel blood test for cardioprotection, supported by a solid $19.38 million cash position.

Optiscan Imaging has submitted its FDA dossier for InSpecta®, marking a crucial step toward US veterinary market entry, while progressing clinical studies for InVue® and InForm® ahead of further FDA submissions in 2026.

hipages Group has acquired a majority stake in VIZ Insurance, marking its strategic entry into the insurance sector for tradies and broadening its platform offerings.

NeuroScientific Biopharmaceuticals reported positive clinical responses in its StemSmart™ Special Access Program for fistulising Crohn’s disease and has initiated manufacturing technology transfer to support Phase 2 trials planned for late 2026.

Recharge Metals has completed the acquisition of the Sunset Well Gold Project near Leonora, WA, backed by a $6 million capital raise. The project hosts a 94,500-ounce inferred gold resource with significant exploration upside.

Gold Hydrogen is poised to begin flow testing at its Ramsay Project, targeting separate Natural Hydrogen and Helium zones, while advancing green methanol and helium commercialisation studies amid robust market demand.

dorsaVi has launched a multi-year partnership with Taiwan’s ITRI and NTU to develop its proprietary RRAM platform at the 22-nm node, complemented by a new advisory board and neuromorphic IP acquisition, positioning the company at the forefront of ultra-edge AI hardware.

Algorae Pharmaceuticals strengthened its balance sheet with $5.47 million cash reserves and broadened its commercial footprint through new licensing deals and AI-driven drug validation.

BlinkLab has completed onboarding all clinical sites for its pivotal FDA autism trial, enrolled the first participant, and launched a nationwide autism screening program in Morocco. A recent A$17.7 million capital raise will fund further trials and expansion into ADHD diagnostics.

Dateline Resources is poised to release its Colosseum Gold Project Bankable Feasibility Study imminently, while expanding rare earth exploration at its new Music Valley project and bolstering its balance sheet with a $50 million placement.

Alara Resources maintained steady copper-gold production at its Al Wash-hi Majaza Mine despite regional geopolitical shipping disruptions, while advancing exploration and managing ongoing legal proceedings in Oman.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Estrella Resources has initiated Timor-Leste’s inaugural hard rock mineral extraction at its Ira Miri manganese project, advancing towards full-scale mining and simultaneously progressing a major limestone resource at Werumata.

ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.

Energy Metals Limited (ASX: EME) reported a 12% increase in uranium resources at its Bigrlyi Project to 10,900 tonnes U3O8, driven by successful drilling and modelling. The company plans to advance technical studies and further exploration in 2026, supported by a solid cash position and strategic backing from China General Nuclear Power Group.

Chalice Mining has bolstered its leadership and financing strategy while advancing a Feasibility Study for its Gonneville palladium-nickel-copper project, amid improving market conditions and promising exploration results.

True North Copper (ASX:TNC) reported robust drilling results confirming the high-grade Aquila discovery at Mt Oxide, a 7% resource increase at Cloncurry, and a strategic JV acquisition with Glencore, setting the stage for a pivotal 2026.

Celsius Resources appoints Bardin Davis as MD to lead financing efforts for the MCB Copper-Gold Project, extends Final Investment Decision timeline to late 2026, and navigates a complex ownership dispute in the Philippines while raising A$9.3 million.

Boss Energy has trimmed its FY26 uranium production guidance due to severe weather disruptions at its Honeymoon project, while advancing a new feasibility study targeting cost reductions with wide-spaced wellfields.

Battery Age Minerals delivered maiden drilling success at Austria’s Bleiberg project, expanded its Apex Germanium-Gallium footprint in Utah by 40%, and confirmed high-grade gold-silver mineralisation at Argentina’s El Aguila. The company also progressed germanium technology evaluations and appointed a new CEO.

Latitude 66 has locked in exploration permits for its high-grade KSB gold-cobalt project in Finland following a key legislative amendment, while its Laverton drilling campaign in Western Australia continues to reveal promising gold mineralisation with potential for resource growth.